21.93
price up icon5.28%   1.10
after-market 시간 외 거래: 22.10 0.17 +0.78%
loading
전일 마감가:
$20.83
열려 있는:
$20.84
하루 거래량:
306.25K
Relative Volume:
1.23
시가총액:
$246.42M
수익:
-
순이익/손실:
$-74.14M
주가수익비율:
-1.9254
EPS:
-11.39
순현금흐름:
$-65.70M
1주 성능:
-23.13%
1개월 성능:
-18.63%
6개월 성능:
+14.88%
1년 성능:
+112.91%
1일 변동 폭
Value
$20.60
$23.59
1주일 범위
Value
$20.60
$29.80
52주 변동 폭
Value
$9.6201
$92.00

인스틸 바이오 Stock (TIL) Company Profile

Name
명칭
Instil Bio Inc
Name
전화
(972) 499-3350
Name
주소
3963 MAPLE AVENUE, DALLAS
Name
직원
14
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
TIL's Discussions on Twitter

TIL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TIL
Instil Bio Inc
21.93 246.42M 0 -74.14M -65.70M -11.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

인스틸 바이오 Stock (TIL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-07 업그레이드 Jefferies Hold → Buy
2024-11-04 개시 JMP Securities Mkt Perform
2024-04-12 다운그레이드 Jefferies Buy → Hold
2022-11-01 다운그레이드 Cowen Outperform → Market Perform
2022-11-01 다운그레이드 Truist Buy → Hold
2021-08-13 개시 Robert W. Baird Outperform
2021-04-13 개시 Cowen Outperform
2021-04-13 개시 Morgan Stanley Equal-Weight
2021-04-13 개시 Truist Buy
모두보기

인스틸 바이오 주식(TIL)의 최신 뉴스

pulisher
Jun 17, 2025

Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a Bet - MSN

Jun 17, 2025
pulisher
Jun 11, 2025

Instil Bio (TIL) Enhances Axion Bio Board with New Appointment | - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Instil Bio Names John Maraganore, Ph.D., to Board Role - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Instil Bio Names John Maraganore, Ph.D., To Board - citybiz

Jun 11, 2025
pulisher
Jun 11, 2025

Instil Bio, Inc. Announces the Addition of John Maraganore, Ph.D., to the Board of Directors of Axion Bio, Inc., Its Wholly-Owned Subsidiary - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program - Yahoo Finance

Jun 11, 2025
pulisher
Jun 06, 2025

(TIL) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 05, 2025

Instil Bio Appoints ‘Seasoned’ Biopharma Exec as Chief Medical Officer - Dallas Innovates

Jun 05, 2025
pulisher
Jun 05, 2025

H.C. Wainwright reiterates Instil Bio stock Buy rating amid partnership news By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Instil Bio (TIL) Receives Reiterated Buy Rating from HC Wainwrig - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

H.C. Wainwright reiterates Instil Bio stock Buy rating amid partnership news - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

Instil Bio (TIL) Receives Reiterated Buy Rating from HC Wainwright & Co. | TIL Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Are You Looking for a Top Momentum Pick? Why Instil Bio, Inc. (TIL) is a Great Choice - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

Instil Bio appoints new Chief Medical Officer By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 02, 2025

Instil Bio (TIL) Rating Reiterated as Market Perform by JMP Secu - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Instil Bio (TIL) Rating Reiterated as Market Perform by JMP Securities | TIL Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Instil Bio (TIL) Appoints Jamie Freedman as Chief Medical Officer - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Instil Bio (TIL) Appoints Jamie Freedman as Chief Medical Officer | TIL Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Instil Bio appoints new Chief Medical Officer - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Former Genentech Executive With 15 FDA Approvals Joins Instil Bio to Accelerate Cancer Drug Development - Stock Titan

Jun 02, 2025
pulisher
Jun 02, 2025

Instil Bio shares hold as JMP reiterates Market Perform rating By Investing.com - Investing.com India

Jun 02, 2025
pulisher
Jun 02, 2025

Instil Bio shares hold as JMP reiterates Market Perform rating - Investing.com Australia

Jun 02, 2025
pulisher
May 31, 2025

Instil Bio (TIL) Upgraded to Buy: What Does It Mean for the Stock? - MSN

May 31, 2025
pulisher
May 30, 2025

Wall Street Analysts Believe Instil Bio (TIL) Could Rally 343.63%: Here's is How to Trade - MSN

May 30, 2025
pulisher
May 30, 2025

Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 30, 2025
pulisher
May 30, 2025

Instil Bio CEO Reveals Latest Pipeline Updates at Prestigious Jefferies Healthcare Conference - Stock Titan

May 30, 2025
pulisher
May 28, 2025

Instil Bio Elects Director and Ratifies Auditor - TipRanks

May 28, 2025
pulisher
May 28, 2025

What's Behind The Big Stock Moves? SPRO, TIL, IMAB.... - Nasdaq

May 28, 2025
pulisher
May 27, 2025

Instil Bio Advances Phase 2 Trial in China - TipRanks

May 27, 2025
pulisher
May 26, 2025

(TIL) Proactive Strategies - news.stocktradersdaily.com

May 26, 2025
pulisher
May 25, 2025

Instil Bio: Second Half 2025 AXN-2510 Data Could Mark Another PD-1/VEGF Success (TIL) - Seeking Alpha

May 25, 2025
pulisher
May 24, 2025

H.C. Wainwright lifts Instil Bio stock target to $125 By Investing.com - Investing.com South Africa

May 24, 2025
pulisher
May 24, 2025

H.C. Wainwright lifts Instil Bio stock target to $125 - Investing.com

May 24, 2025
pulisher
May 24, 2025

Instil Bio (TIL) Receives Price Target Upgrade by HC Wainwright & Co. | TIL Stock News - GuruFocus

May 24, 2025
pulisher
May 24, 2025

H.C. Wainwright Boosts Instil Bio (TIL) Price Target Following P - GuruFocus

May 24, 2025
pulisher
May 23, 2025

Instil Bio and ImmuneOnco to Host Investor and Analyst - GlobeNewswire

May 23, 2025
pulisher
May 23, 2025

Instil Bio and ImmuneOnco Announce Joint Investor Breakfast in Chicago to Discuss Immuno-Oncology Developments - Nasdaq

May 23, 2025
pulisher
May 23, 2025

Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving ... - Bluefield Daily Telegraph

May 23, 2025
pulisher
May 23, 2025

H.C. Wainwright Boosts Instil Bio (TIL) Price Target Following Positive Data Release | TIL Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving PD-(L)1xVEGF Bispecific Antibody Landscape and Clinical Trial Updates During the 2025 ASCO Annual Meeting in Chicago - GlobeNewswire

May 23, 2025
pulisher
May 22, 2025

Instil Bio (TIL) Advances Clinical Trials for NSCLC Treatment | - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Instil Bio and ImmuneOnco Announced the Phase 2 Trial in - GlobeNewswire

May 22, 2025

인스틸 바이오 (TIL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):